Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-30 to 2024-02-21
Current total value of award: $74275.2
Description: 4563651594!XOLAIR 150 MG/ML SYRINGEML